[NESTLE] YoY Annualized Quarter Result on 30-Sep-2002 [#3]

Stock
[NESTLE] NESTLE (M) BHD
Announcement Date
06-Nov-2002
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2002
Quarter
30-Sep-2002 [#3]
Profit Trend
QoQ- 5.98%
YoY- 0.69%
Quarter Report
Latest QR
Upcoming QR
NESTLE's Result
NESTLE's Financial Summary
View:
Show?
Annualized Quarter Result
30/09/05 30/09/04 30/09/03 30/09/02 30/09/01 30/09/00 30/09/99 CAGR
Revenue 3,138,161 2,920,256 2,671,397 2,624,796 2,604,894 2,198,554 2,009,845 -0.47%
PBT 358,200 328,038 212,338 267,572 280,793 265,088 229,561 -0.47%
Tax -60,397 -86,120 -46,609 -56,998 -71,653 -57,317 -6,409 -2.35%
NP 297,802 241,918 165,729 210,573 209,140 207,770 223,152 -0.30%
-
NP to SH 297,802 241,918 165,729 210,573 209,140 207,770 223,152 -0.30%
-
Tax Rate 16.86% 26.25% 21.95% 21.30% 25.52% 21.62% 2.79% -
Total Cost 2,840,358 2,678,337 2,505,668 2,414,222 2,395,754 1,990,784 1,786,693 -0.49%
-
Net Worth 410,358 321,276 269,701 377,587 365,815 349,411 429,138 0.04%
Dividend
30/09/05 30/09/04 30/09/03 30/09/02 30/09/01 30/09/00 30/09/99 CAGR
Div 78,788 109,437 109,443 93,810 93,798 - - -100.00%
Div Payout % 26.46% 45.24% 66.04% 44.55% 44.85% - - -
Equity
30/09/05 30/09/04 30/09/03 30/09/02 30/09/01 30/09/00 30/09/99 CAGR
Net Worth 410,358 321,276 269,701 377,587 365,815 349,411 429,138 0.04%
NOSH 234,490 234,508 234,522 234,526 234,496 234,504 234,501 0.00%
Ratio Analysis
30/09/05 30/09/04 30/09/03 30/09/02 30/09/01 30/09/00 30/09/99 CAGR
NP Margin 9.49% 8.28% 6.20% 8.02% 8.03% 9.45% 11.10% -
ROE 72.57% 75.30% 61.45% 55.77% 57.17% 59.46% 52.00% -
Per Share
30/09/05 30/09/04 30/09/03 30/09/02 30/09/01 30/09/00 30/09/99 CAGR
RPS 1,338.29 1,245.27 1,139.08 1,119.19 1,110.84 937.53 857.07 -0.47%
EPS 127.00 103.16 70.67 89.79 89.19 88.60 95.16 -0.30%
DPS 33.60 46.67 46.67 40.00 40.00 0.00 0.00 -100.00%
NAPS 1.75 1.37 1.15 1.61 1.56 1.49 1.83 0.04%
Adjusted Per Share Value based on latest NOSH - 234,511
30/09/05 30/09/04 30/09/03 30/09/02 30/09/01 30/09/00 30/09/99 CAGR
RPS 1,338.24 1,245.31 1,139.19 1,119.32 1,110.83 937.55 857.08 -0.47%
EPS 126.99 103.16 70.67 89.80 89.19 88.60 95.16 -0.30%
DPS 33.60 46.67 46.67 40.00 40.00 0.00 0.00 -100.00%
NAPS 1.7499 1.37 1.1501 1.6102 1.56 1.49 1.83 0.04%
Price Multiplier on Financial Quarter End Date
30/09/05 30/09/04 30/09/03 30/09/02 30/09/01 30/09/00 30/09/99 CAGR
Date 30/09/05 30/09/04 30/09/03 30/09/02 28/09/01 29/09/00 - -
Price 24.90 22.70 21.00 20.20 20.20 20.00 0.00 -
P/RPS 1.86 1.82 1.84 1.80 1.82 2.13 0.00 -100.00%
P/EPS 19.61 22.00 29.72 22.50 22.65 22.57 0.00 -100.00%
EY 5.10 4.54 3.37 4.44 4.42 4.43 0.00 -100.00%
DY 1.35 2.06 2.22 1.98 1.98 0.00 0.00 -100.00%
P/NAPS 14.23 16.57 18.26 12.55 12.95 13.42 0.00 -100.00%
Price Multiplier on Announcement Date
30/09/05 30/09/04 30/09/03 30/09/02 30/09/01 30/09/00 30/09/99 CAGR
Date 10/11/05 04/11/04 02/01/04 06/11/02 06/11/01 22/11/00 11/11/99 -
Price 24.60 22.60 21.80 19.30 20.20 19.00 0.00 -
P/RPS 1.84 1.81 1.91 1.72 1.82 2.03 0.00 -100.00%
P/EPS 19.37 21.91 30.85 21.50 22.65 21.44 0.00 -100.00%
EY 5.16 4.56 3.24 4.65 4.42 4.66 0.00 -100.00%
DY 1.37 2.06 2.14 2.07 1.98 0.00 0.00 -100.00%
P/NAPS 14.06 16.50 18.96 11.99 12.95 12.75 0.00 -100.00%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment